Yun Xiao

发表

A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.

Wei Zheng, Kwok-Kin Wong, Nathanael S Gray, 2011, Cancer research.

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

Luca Toschi, A. Iafrate, P. Jänne, 2010, Cancer cell.

Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis

Humam Kadara, Diane D. Liu, Diane D Liu, 2011, Clinical Cancer Research.

The DNA Methylome and Transcriptome of Different Brain Regions in Schizophrenia and Bipolar Disorder

Yun Xiao, Yunpeng Zhang, Chun Xu, 2014, PloS one.

TLR 4 / NF-κB axis signaling pathway-dependent up-regulation of miR-625-5 p contributes to human intervertebral disc degeneration by targeting COL 1 A 1

Ling Liu, Yun Xiao, Caiguo Zhang, 2019 .

The implication from RAS/RAF/ERK signaling pathway increased activation in epirubicin treated triple negative breast cancer

G. Ren, Yun Xiao, Hong-Yuan Li, 2017, Oncotarget.

EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.

Charles Lee, P. Jänne, B. Yeap, 2010, American journal of clinical pathology.

Fluorescence in situ hybridization (FISH) subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in NSCLC

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2007 .

Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis

Jing Li, Jing Liu, Bo Huang, 2011, International journal of molecular medicine.

Imatinib regulates the alternative pre-mRNA splicing of Bcl-x in K562 cells

Jing Li, Jing Liu, Bo Huang, 2012 .

Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway

Yun Xiao, Jun Zhou, M. Liang, 2019, Cell Division.

Aberrant Expression of Splicing Factors in Newly Diagnosed Acute Myeloid Leukemia

Jing Li, Jing Liu, Bo Huang, 2012, Oncology Research and Treatment.

Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation

M. Varella‐Garcia, M. Iruela-Arispe, W. Guo, 2008, Nature.

Zinc-Finger Protein 545 Inhibits Cell Proliferation as a Tumor Suppressor through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer

Q. Tao, Lili Li, G. Ren, 2014, PloS one.

Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

P. D. Dal Cin, J. Aster, J. Bradner, 2009, Proceedings of the National Academy of Sciences.

Identification and Characterization of Immunogene-Related Alternative Splicing Patterns and Tumor Microenvironment Infiltration Patterns in Breast Cancer

Peng Wang, Hui Zhi, Xuepeng Wang, 2022, Cancers.

Novel Prognostic Implications of PAQR3 Expression in Breast Cancer after Curative Resection and Systemic Therapy

Yun Xiao, Purong Zhang, S. Lei, 2021 .

MAPK Pathway Inhibition as A Rational Therapeutic Strategy for MiR-138-5p/PAQR3 Dysregulation-mediated Epirubicin Resistance in Triple-negative Breast Cancer

Xiaoyi Wang, G. Ren, Yun Xiao, 2021, bioRxiv.

Fluorescence In situ Hybridization Subgroup Analysis ofTRIBUTE , a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non ^ Small Cell Lung Cancer

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2008 .

TLR4/NF-κB axis signaling pathway-dependent up-regulation of miR-625-5p contributes to human intervertebral disc degeneration by targeting COL1A1.

Ling Liu, Yun Xiao, Caiguo Zhang, 2019, American journal of translational research.

miR-454-3p inhibits non-small cell lung cancer cell proliferation and metastasis by targeting TGFB2

Yun Xiao, Tao Yu, Hong-yin Liao, 2021, Oncology reports.

Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway

Yun Xiao, Jun Zhou, Yang Zou, 2019, Cell Division.

Fluorescence In situ Hybridization Subgroup Analysis of TRIBUTE, a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non–Small Cell Lung Cancer

F. Hirsch, P. Bunn, M. Varella‐Garcia, 2008, Clinical Cancer Research.

Increased tumor-associated mast cells facilitate thyroid cancer progression by inhibiting CD8+ T cell function through galectin-9

Yun Xiao, Ying Zhu, Qiang Wang, 2023, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

The topoisomerase inhibitor CPT-11 prevents the growth and metastasis of lung cancer cells in nude mice by inhibiting EGFR/MAPK signaling pathway

Huiying Zheng, Yun Xiao, Lingzhi Yin, 2023, Heliyon.

Complex I mutations synergize to worsen the phenotypic expression of Leber's hereditary optic neuropathy

Rulai Yang, Yun Xiao, M. Guan, 2020, The Journal of Biological Chemistry.

RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.

Yun Xiao, T. Xiang, Cong Luo, 2014, Molecular immunology.

Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor

P. Jänne, J. Engelman, J. Christensen, 2010, Oncogene.

MiR-934 Exacerbates Malignancy of Gastric Cancer Cells by Targeting ZFP36

Ge Zhang, Yun Xiao, Guodong Liu, 2023, Iranian Journal of Public Health.